Tower Research Capital (TRC)’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.8K Buy
8,449
+5,476
+184% +$44.6K ﹤0.01% 2702
2025
Q1
$23.3K Sell
2,973
-4,210
-59% -$33K ﹤0.01% 2820
2024
Q4
$107K Buy
7,183
+456
+7% +$6.79K ﹤0.01% 2115
2024
Q3
$103K Sell
6,727
-11,788
-64% -$180K ﹤0.01% 2213
2024
Q2
$282K Buy
18,515
+17,928
+3,054% +$273K ﹤0.01% 1818
2024
Q1
$11.1K Sell
587
-1,927
-77% -$36.4K ﹤0.01% 3605
2023
Q4
$48K Sell
2,514
-2,270
-47% -$43.4K ﹤0.01% 3158
2023
Q3
$85.9K Sell
4,784
-2,594
-35% -$46.6K ﹤0.01% 2092
2023
Q2
$150K Buy
7,378
+3,490
+90% +$70.9K 0.01% 1741
2023
Q1
$71K Sell
3,888
-3,246
-46% -$59.3K ﹤0.01% 2189
2022
Q4
$147K Buy
7,134
+2,710
+61% +$55.8K 0.01% 1531
2022
Q3
$115K Sell
4,424
-8,550
-66% -$222K ﹤0.01% 2449
2022
Q2
$329K Buy
12,974
+10,428
+410% +$264K 0.01% 1416
2022
Q1
$81K Sell
2,546
-2,050
-45% -$65.2K ﹤0.01% 2369
2021
Q4
$186K Sell
4,596
-2,955
-39% -$120K ﹤0.01% 1828
2021
Q3
$263K Buy
7,551
+2,922
+63% +$102K 0.01% 1553
2021
Q2
$128K Sell
4,629
-46
-1% -$1.27K ﹤0.01% 2223
2021
Q1
$131K Buy
4,675
+2,699
+137% +$75.6K ﹤0.01% 2360
2020
Q4
$51K Sell
1,976
-4,992
-72% -$129K ﹤0.01% 3107
2020
Q3
$119K Sell
6,968
-13,651
-66% -$233K ﹤0.01% 3016
2020
Q2
$510K Buy
+20,619
New +$510K 0.02% 1017
2019
Q4
Sell
-1,052
Closed -$10K 4223
2019
Q3
$10K Buy
+1,052
New +$10K ﹤0.01% 2940
2019
Q2
Sell
-4,870
Closed -$61K 4169
2019
Q1
$61K Buy
+4,870
New +$61K ﹤0.01% 1675
2018
Q4
Sell
-56
Closed -$1K 4260
2018
Q3
$1K Sell
56
-2,160
-97% -$38.6K ﹤0.01% 3611
2018
Q2
$27K Buy
+2,216
New +$27K ﹤0.01% 2242